Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,147
archived clinical trials in
Asthma

Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
2016
mi
from 91732
Bristol, TN
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
2016
mi
from 91732
Bristol, TN
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
1763
mi
from 91732
Nashville, TN
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
1763
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
1763
mi
from 91732
Nashville, TN
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
1763
mi
from 91732
Nashville, TN
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
1204
mi
from 91732
Arlington, TX
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
1204
mi
from 91732
Arlington, TX
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
1225
mi
from 91732
Dallas, TX
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
1225
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
686
mi
from 91732
El Paso, TX
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
686
mi
from 91732
El Paso, TX
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
1232
mi
from 91732
McKinney, TX
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
1232
mi
from 91732
McKinney, TX
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
1188
mi
from 91732
San Antonio, TX
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
1188
mi
from 91732
San Antonio, TX
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
1188
mi
from 91732
San Antonio, TX
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
1188
mi
from 91732
San Antonio, TX
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
586
mi
from 91732
Clinton, UT
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
586
mi
from 91732
Clinton, UT
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
1039
mi
from 91732
Bellingham, WA
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
1039
mi
from 91732
Bellingham, WA
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Clinical Research Facility
1722
mi
from 91732
Milwaukee, WI
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Clinical Research Facility
1722
mi
from 91732
Milwaukee, WI
Click here to add this to my saved trials
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated:  3/14/2016
Research Site
7456
mi
from 91732
New Lambton,
Study of Efficacy and Safety of Brodalumab Compared With Placebo in Inadequately Controlled Asthma Subjects With High Bronchodilator Reversibility
A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Brodalumab in Subjects With Inadequately Controlled Asthma and High Bronchodilator Reversibility
Status: Enrolling
Updated: 3/14/2016
Research Site
7456
mi
from 91732
New Lambton,
Click here to add this to my saved trials
Antioxidant Therapy in Lean and Obese Asthmatics
Phase 2 Study of Antioxidant Therapy in Lean and Obese Asthmatics
Status: Enrolling
Updated:  3/21/2016
Nemours Children's Clinic
2130
mi
from 91732
Jacksonville, FL
Antioxidant Therapy in Lean and Obese Asthmatics
Phase 2 Study of Antioxidant Therapy in Lean and Obese Asthmatics
Status: Enrolling
Updated: 3/21/2016
Nemours Children's Clinic
2130
mi
from 91732
Jacksonville, FL
Click here to add this to my saved trials
Study to Examine the Cytokine Levels, Gene Expression and Safety of a Single Nasal Dose of JNJ-43260295, in Healthy Participants, and Atopic Participants With Mild to Mild-Persistent Asthma
A Phase 1 Study to Examine the Cytokine Levels, Gene Expression and Safety of a Single Nasal Dose of JNJ-43260295, in a Double-Blind, Randomized, Placebo-Controlled Setting in Healthy Subjects, and by an Open-Label Assessment in Atopic Subjects With Mild to Mild-Persistent Asthma With and Without Nasal Allergen Challenge Prior to Dosing
Status: Enrolling
Updated:  3/22/2016
Clinical Research Facility
2208
mi
from 91732
Charlottesville, VA
Study to Examine the Cytokine Levels, Gene Expression and Safety of a Single Nasal Dose of JNJ-43260295, in Healthy Participants, and Atopic Participants With Mild to Mild-Persistent Asthma
A Phase 1 Study to Examine the Cytokine Levels, Gene Expression and Safety of a Single Nasal Dose of JNJ-43260295, in a Double-Blind, Randomized, Placebo-Controlled Setting in Healthy Subjects, and by an Open-Label Assessment in Atopic Subjects With Mild to Mild-Persistent Asthma With and Without Nasal Allergen Challenge Prior to Dosing
Status: Enrolling
Updated: 3/22/2016
Clinical Research Facility
2208
mi
from 91732
Charlottesville, VA
Click here to add this to my saved trials
Identification of Molecular Biomarkers to Stratify Patients With Refractory Asthma
Identification of Molecular Biomarkers to Stratify Patients With Refractory Asthma
Status: Enrolling
Updated:  3/23/2016
National Jewish Health
819
mi
from 91732
Denver, CO
Identification of Molecular Biomarkers to Stratify Patients With Refractory Asthma
Identification of Molecular Biomarkers to Stratify Patients With Refractory Asthma
Status: Enrolling
Updated: 3/23/2016
National Jewish Health
819
mi
from 91732
Denver, CO
Click here to add this to my saved trials
How Does the Clinical Tool 'What's Going Around' Affect Clinical Practice
How Does the Clinical Tool 'What's Going Around' Affect Clinical Practice
Status: Enrolling
Updated:  3/30/2016
NorthShore University HealthSystem
1728
mi
from 91732
Evanston, IL
How Does the Clinical Tool 'What's Going Around' Affect Clinical Practice
How Does the Clinical Tool 'What's Going Around' Affect Clinical Practice
Status: Enrolling
Updated: 3/30/2016
NorthShore University HealthSystem
1728
mi
from 91732
Evanston, IL
Click here to add this to my saved trials
Role of the Isomerase Pin-1 in the Development and Treatment of Asthma
Role of the Isomerase Pin-1 in the Development and Treatment of Asthma
Status: Enrolling
Updated:  3/31/2016
Asthma Research Center
2578
mi
from 91732
Boston, MA
Role of the Isomerase Pin-1 in the Development and Treatment of Asthma
Role of the Isomerase Pin-1 in the Development and Treatment of Asthma
Status: Enrolling
Updated: 3/31/2016
Asthma Research Center
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
1459
mi
from 91732
Little Rock, AR
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
1459
mi
from 91732
Little Rock, AR
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
216
mi
from 91732
Fresno, CA
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
216
mi
from 91732
Fresno, CA
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
24
mi
from 91732
Los Angeles, CA
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
24
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
31
mi
from 91732
Newport Beach, CA
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
31
mi
from 91732
Newport Beach, CA
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
37
mi
from 91732
Riverside, CA
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
37
mi
from 91732
Riverside, CA
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
27
mi
from 91732
Rolling Hills Estates, CA
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
27
mi
from 91732
Rolling Hills Estates, CA
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
99
mi
from 91732
San Diego, CA
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
99
mi
from 91732
San Diego, CA
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
20
mi
from 91732
Upland, CA
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
20
mi
from 91732
Upland, CA
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
1980
mi
from 91732
Tallahassee, FL
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
1980
mi
from 91732
Tallahassee, FL
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
1739
mi
from 91732
Owensboro, KY
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
1739
mi
from 91732
Owensboro, KY
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
2301
mi
from 91732
Baltimore, MD
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
2301
mi
from 91732
Baltimore, MD
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
2287
mi
from 91732
Columbia, MD
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
2287
mi
from 91732
Columbia, MD
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
1509
mi
from 91732
Minneapolis, MN
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
1509
mi
from 91732
Minneapolis, MN
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
1502
mi
from 91732
Plymouth, MN
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
1502
mi
from 91732
Plymouth, MN
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
2272
mi
from 91732
Corning, NY
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
2272
mi
from 91732
Corning, NY
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
2100
mi
from 91732
Charlotte, NC
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
2100
mi
from 91732
Charlotte, NC
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
2062
mi
from 91732
Shelby, NC
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
2062
mi
from 91732
Shelby, NC
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
1880
mi
from 91732
Cincinnati, OH
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
1880
mi
from 91732
Cincinnati, OH
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
628
mi
from 91732
Medford, OR
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
628
mi
from 91732
Medford, OR
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
2121
mi
from 91732
Pittsburgh, PA
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
2121
mi
from 91732
Pittsburgh, PA
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
2022
mi
from 91732
Greenville, SC
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
2022
mi
from 91732
Greenville, SC
Click here to add this to my saved trials
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated:  3/31/2016
GSK Investigational Site
7294
mi
from 91732
Coffs Harbour,
Cross-sectional Study for Identification and Description of Severe Asthma Patients
Identification and Description of Severe Asthma Patients in a Cross-sectional Study—the IDEAL Study
Status: Enrolling
Updated: 3/31/2016
GSK Investigational Site
7294
mi
from 91732
Coffs Harbour,
Click here to add this to my saved trials
Flexibility and Strength Training in Asthma
FASTA: Flexibility and Strength Training in Asthma
Status: Enrolling
Updated:  3/31/2016
Brigham and Women's Hosp
2578
mi
from 91732
Boston, MA
Flexibility and Strength Training in Asthma
FASTA: Flexibility and Strength Training in Asthma
Status: Enrolling
Updated: 3/31/2016
Brigham and Women's Hosp
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
1787
mi
from 91732
Hoover, AL
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
1787
mi
from 91732
Hoover, AL
Click here to add this to my saved trials
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
1831
mi
from 91732
Montgomery, AL
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
1831
mi
from 91732
Montgomery, AL
Click here to add this to my saved trials
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
363
mi
from 91732
Gilbert, AZ
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
363
mi
from 91732
Gilbert, AZ
Click here to add this to my saved trials
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
1463
mi
from 91732
Little Rock, AR
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
1463
mi
from 91732
Little Rock, AR
Click here to add this to my saved trials
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
28
mi
from 91732
Huntington Beach, CA
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
28
mi
from 91732
Huntington Beach, CA
Click here to add this to my saved trials
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
21
mi
from 91732
Long Beach, CA
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
21
mi
from 91732
Long Beach, CA
Click here to add this to my saved trials
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
37
mi
from 91732
Mission Viejo, CA
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
37
mi
from 91732
Mission Viejo, CA
Click here to add this to my saved trials
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
31
mi
from 91732
Newport Beach, CA
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
31
mi
from 91732
Newport Beach, CA
Click here to add this to my saved trials
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated:  4/5/2016
Clinical Research Facility
20
mi
from 91732
Ontario, CA
A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg
A Phase 3, 12-Week, Double-Blind, Randomized, Parallel-Group, Multicenter Study Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg, 2 Actuations Twice Daily, and Symbicort pMDI 80/4.5 μg, 2 Actuations Twice Daily, Compared With Budesonide pMDI 80 μg, 2 Actuations Twice Daily, in Children Ages 6 to <12 Years With Asthma
Status: Enrolling
Updated: 4/5/2016
Clinical Research Facility
20
mi
from 91732
Ontario, CA
Click here to add this to my saved trials